Skip to content
Search

Latest Stories

US tech firm Palantir wins NHS Data Platform contract

US tech firm Palantir wins NHS Data Platform contract

The contract award will see investment of up to £330m over the course of seven years

NHS England is set to introduce a new tool from spring next year to improve care for millions of patients, tackle waiting lists and reduce hospital discharge delays.


The new tool, known as the Federated Data Platform, will bring together key information currently held in separate NHS systems such as the number of beds in a hospital, the size of elective waiting lists, staff rosters, the availability of medical supplies and social care places.

The contract to provide the software has been awarded to US data analytics giant Palantir, with support from Accenture, PwC, NECS and Carnall Farrar.

Over the contractual period of seven years, the NHS will be investing up to £330m in the  data platform and associated services.

In the first contract year, investment is expected to be at least £25.6m, NHSE confirmed on Tuesday (21 November).

Announcing the contract, NHS National Director for Transformation Dr Vin Diwakar said: “Better use of data is essential for the NHS to tackle waiting times, join up patient care and make the health service sustainable for the future.

“Patients come to the NHS at some of the most vulnerable points in their lives, and they want to know that our healthcare teams have access to the best possible information when it comes to their treatment and care.

“This new tool provides a safe and secure environment to bring together data, which enables us to develop and deliver more responsive services for patients and will help the health service drive the recovery in elective care.”

Palantir CEO Alex Karp said that their software can integrate complex, sensitive data in a way that “protects security, respects privacy and puts the customer in full control.”

The NHS also ensured that no company involved in the Federated Data Platform can access health and care data without its permission.

“All data within the platform is under the control of the NHS and will only be used for direct care and planning. It will not be used to access data for research purposes and GP data will not feed into the national version of the software platform,” it said.

Every hospital trust and local health system will have their own version of the software, which enables them to connect and share information between them.

North Tees and Hartlepool Trust, where the system was introduced under pilot projects, has been able to reduce long term stays (21 days or more) by 36 per cent despite increased demand, with 7.7 per cent more patients being admitted to the hospital.

NHSE noted that the new Federated Data Platform builds on the success of the current National Data Platform, for which the contract is about to come to an end.

It will be the first use case in the NHS of Privacy Enhancing Technology (NHS-PET), a nationally assured and funded privacy tool to benefit all NHS organisations.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less